<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Desmocollin-2 (Dsc2) and desmoglein-2 (Dsg2) are transmembrane cell <z:e sem="disease" ids="C0001511" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">adhesion</z:e> proteins of desmosomes </plain></SENT>
<SENT sid="1" pm="."><plain>Reduced expression of Dsc2 has been reported in colorectal <z:mp ids='MP_0002038'>carcinomas</z:mp>, suggesting that Dsc2 may play a role in the development and/or progression of <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain>However, no studies have examined the mechanistic contribution of Dsc2 deficiency to <z:mp ids='MP_0002006'>tumorigenesis</z:mp> </plain></SENT>
<SENT sid="3" pm="."><plain>Here we report that loss of Dsc2 promotes cell proliferation and enables <z:e sem="disease" ids="C0598934" disease_type="Neoplastic Process" abbrv="">tumor growth</z:e> in vivo through the activation of Akt/β-catenin signaling </plain></SENT>
<SENT sid="4" pm="."><plain>Inhibition of Akt prevented the increase in β-catenin-dependent transcription and proliferation following Dsc2 knockdown and attenuated the in vivo growth of Dsc2-deficient cells </plain></SENT>
<SENT sid="5" pm="."><plain>Taken together, our results provide evidence that loss of Dsc2 contributes to the growth of <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> cells and highlight a novel mechanism by which the desmosomal cadherins regulate β-catenin signaling </plain></SENT>
</text></document>